Please login to the form below

Not currently logged in
Email:
Password:

New accounts: February

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period November 2004 to January 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period November 2004 to January 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com.

Client

Product

Therapeutic area

Winning agency

Alliance Pharmaceuticals

Alphaderm

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Aquadrate

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Acnisal

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Occlusal

Dermatology

RFA Advertising

AstraZeneca

Arimidex

Oncology

Brader Perryman

Biogen

Avonex

Multiple sclerosis

Brader Perryman

Eden Biodesign

N/A

Corporate

Affiniti (UK)

Ferring

Gonapeptyl and Norprolac

Fertility

MJL Advertising

Mencap

Corporate

Learning disabilities

MJL Advertising

Merck Sharp & Dohme

Maxalt

Migraine

PAN Advertising

Novartis

Fortekor

CHF

MJL Advertising

Novartis

Prexige

Osteoarthritis

Brader Perryman

Novartis

Exelon

Alzheimer's disease

Brader Perryman

Servier Laboratories

Procoralan

Cardiovascular

PAN Advertising

Solvay

Omacor

Cardiovascular

Life

Takeda

N/A

Corporate

Brader Perryman

Takeda

Actos

Diabetes

Brader Perryman

Takeda

Amias

Hypertension

Brader Perryman

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics